DaVita is a regular target of government enforcement actions involving fraud and illegal kickbacks. It has an extensive history of violations and settlements. here is a list of some of the highlights: ...
R1 Therapeutics launches with $78 million funding round, secures kidney disorder treatment license R1 Therapeutics said on Tuesday it had launched operations with a $77.5 million Series A funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results